CD19 Rituximab
- Description
- This protocol provides the client with a CD19 and CD20 B panel for the monitoring of rituximab treatment.
- Clinical details
- Rituximab is a chimeric anti-human monoclonal antibody that reacts with the CD20 antigen and is used to treat B cell lymphoma in the adult. It is also used to treat moderate-to-severe forms of Rheumatoid arthritis and other diseases involving the immune system.
- Related condition
- Synonyms
- CD19 Rituximab protocol, CLL, Rheumatoid arthritis, Immunophenotyping Rituximab monitoring.
- Testing site
- Synnovis : Blood Sciences : Guy's Hospital
- Laboratory
- Flow Cytometry/ Immunophenotyping
- Sample type and volume required
- EDTA Whole Blood 1ml
- Special sample instructions
Do not refrigerate samples
- Storage and transport
- Store and transport samples at room temperature. Maximum sample age for analysis is 48hrs.
- Turnaround time
- 48 hours
- Contacts
Flow Cytometry/Immunophenotyping Laboratory at Guy’s and St Thomas’ Clinical Advisory Service
Guy’s Hospital
Phone: 020 7188 2709 Monday – Friday 9:00 – 17:00
4th Floor – Southwark Wing
Great Maze Pond
London SE1 9RTSt Thomas’ Hospital
Phone: 020 7188 3421 Monday – Friday 09:00 – 17:00
5th Floor – North Wing
Westminster Bridge Road
London SE1 7EH